tirzepatide name Medical Weight Loss How the weight loss drug

After stopping use of semaglutide medications, some individuals may experience a return of appetite and potential weight regain

Limited data while early indications are positive for the use of GLP-1s as part of comprehensive treatment for chronic inflammatory conditions, there is still limited data to support this use

TRIUMPH-3 Results in Detail TRIUMPH-3 enrolled 1,949 adults with severe obesity (BMI 35) and established cardiovascular disease, with or without type 2 diabetes, randomized 1:1:2 to retatrutide 9mg, 12mg, or placebo over 80 weeks

Contact your GP if fatigue persists beyond several months, worsens progressively, significantly impairs daily activities, or is accompanied by severe gastrointestinal symptoms, signs of dehydration, or symptoms of hypoglycaemia